Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness of Adjuvant Octreotide Therapy in High Recurrence Risk Patients With Pancreatic Neuroendocrine Tumors

NCT06080204 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06080204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06080204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness of Adjuvant Octreotide Therapy in High Recurrence Risk Patients With Pancreatic Neuroendocrine Tumors
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2008
Completion date
April 30, 2020
Enrollment
411 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neuroendocrine tumor g2